Shen Neil Nanpeng’s Burning Rock Biotech BNR Stock Holding History

Shen Neil Nanpeng’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-885	Closed	-$36.3K	–	1
2025 Q4	$36.3K	Hold	885	–	–	100%	1
2025 Q3	$8.98K	Hold	885	–	–	10.15%	2
2025 Q2	$2.8K	Hold	885	–	–	100%	1
2025 Q1	$2.6K	Hold	885	–	–	1.55%	3
2024 Q4	$5.65K	Hold	885	–	–	4.54%	3
2024 Q3	$5.65K	Hold	885	–	–	4.54%	3
2024 Q2	$761	Buy	885 +796	+894%	+$6.06K	0.52%	3
2024 Q1	$761	Hold	89	–	–	0.52%	3
2023 Q4	$841	Hold	89	–	–	0.47%	4
2023 Q3	$858	Hold	89	–	–	0.02%	7
2023 Q2	$1.85K	Hold	89	–	–	0.05%	6
2023 Q1	$2.49K	Hold	89	–	–	0.09%	5
2022 Q4	$1.99K	Hold	89	–	–	0.05%	4
2022 Q3	$2K	Hold	89	–	–	0.03%	3
2022 Q2	$3K	Hold	89	–	–	0.03%	4
2022 Q1	$8	Hold	89	–	–	0.05%	4
2021 Q4	$8K	Hold	89	–	–	0.34%	4
2021 Q3	$16K	Hold	89	–	–	0.51%	4
2021 Q2	$26K	Hold	89	–	–	0.36%	6
2021 Q1	$24K	Hold	89	–	–	0.04%	7
2020 Q4	$20K	Buy	+89	New	+$23.9K	0.04%	5

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

CRCM LP San Francisco, California $141M AUM 153.09% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RWMG

Redwood Wealth Management Group Medford, New Jersey $232M AUM 22.66% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

Shen Neil Nanpeng's BNR Position: Q1 2026 in Review

Shen Neil Nanpeng sold out of Burning Rock Biotech (BNR) in Q1 2026, closing a stake of 885 shares — an estimated $36.3K sold.

Shen Neil Nanpeng first reported a position in BNR in Q4 2020 and held it in 21 quarters. The position peaked at $36.3K in Q4 2025. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.

Shen Neil Nanpeng reported no remaining Burning Rock Biotech position as of Q1 2026 after selling out during the quarter.
Shen Neil Nanpeng sold 885 Burning Rock Biotech shares in Q1 2026, an estimated $36.3K.
Shen Neil Nanpeng first reported a position in Burning Rock Biotech in Q4 2020 and held it in 21 quarters.
Shen Neil Nanpeng's Burning Rock Biotech position peaked at $36.3K in Q4 2025.
16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.

Based on Shen Neil Nanpeng's 13F filing for Q1 2026.